The 4th Annual Echo in Pediatric and Congenital Heart Disease is a two-day virtual course ( 06/28/2025 – 06/29/2025), presenting the latest information on established and emerging cardiovascular ultrasound technologies, clinical care and practical considerations in children and adults with congenital heart disease. Expert physician and sonographer faculty discuss current technologies with a particular focus on how they can be effectively applied in the clinical setting.
Include:
Coronary Artery Imaging & Anomalies
Rings & Slings
Jeopardy
Fetal Echocardiography Cases: Torture The Experts!
Neonatology
DORV
Early Career Discussions
International Session
Learning Objectives:
At the end of this course, that participant will be able to:
Describe imaging goals and approaches to a variety of challenging forms of congenital heart disease, from infancy to adulthood.
Understand and apply current techniques in imaging assessment of cardiac anatomy and function, including contrast imaging in pediatrics, advanced 3D echo, myocardial work and CRT in children.
Apply techniques to promote well-being, resiliency, and career advancement of your entire sonographer team.
Chairs: Shiraz Maskatia MD, FASE and Jennifer Acevedo ACS, RDCS, FASE
The ASE 4th Annual Echo in Pediatric & Congenital Heart Disease Virtual Experience (June 28–29, 2025) is best for pediatric cardiologists, congenital heart disease sonographers, pediatric intensivists, and multidisciplinary clinicians who perform or interpret pediatric/CHD echocardiography and need a focused, practice‑applicable update delivered virtually.
Who this course is best for
Primary audience: Pediatric cardiologists; congenital heart disease (CHD) specialists; pediatric sonographers; pediatric intensivists; echo lab directors.
Also valuable for: Adult congenital heart disease clinicians, fellows, advanced practice providers, and imaging specialists who manage children or adults with CHD and want practical ultrasound‑based updates.
+ Topics:
Agenda Now Available!





Reviews
There are no reviews yet.